+

PE20070109A1 - Procesos para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina - Google Patents

Procesos para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina

Info

Publication number
PE20070109A1
PE20070109A1 PE2006000628A PE2006000628A PE20070109A1 PE 20070109 A1 PE20070109 A1 PE 20070109A1 PE 2006000628 A PE2006000628 A PE 2006000628A PE 2006000628 A PE2006000628 A PE 2006000628A PE 20070109 A1 PE20070109 A1 PE 20070109A1
Authority
PE
Peru
Prior art keywords
methyl
imidazol
trifluoromethyl
benzenamine
synthesis
Prior art date
Application number
PE2006000628A
Other languages
English (en)
Inventor
Stephan Abel
Murat Acemoglu
Christoph Krell
Mark Meisenbach
Wen-Chung Shieh
Song Xue
Mahavir Prashad
Joseph Sclafani
Bernhard Erb
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37149980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20070109(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20070109A1 publication Critical patent/PE20070109A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

SE REFIERE A UN PROCESO PARA LA PREPARACION DE 5-(4-METIL-1H-IMIDAZOL-1-IL)-3-(TRIFLUOROMETIL)-BENCENAMIDA, EL CUAL COMPRENDE: A) HACER REACCIONAR 4-METIL-1H-IMIDAZOL CON UN COMPUESTO DE FORMULA I, DONDE X ES HALOGENO, SULFONATO, NO2; Y ES NH2, NO2, HALOGENO, CN EN PRESENCIA DE UNA BASE ADECUADA SELECCIONADA ENTRE ALCOXIDO DE POTASIO, ALCOXIDO DE SODIO, HIDRURO DE POTASIO, CARBONATO DE LITIO, CESIO, ENTRE OTROS. SE CONDUCE A UNA TEMPERATURA DE 70 A 130 C; B) REDUCIR EL 4-METIL-1-(3-NITRO-5-TRIFLUORO-METIL-FENIL)-1H-IMIDAZOL CON UN CATALIZADOR DE METAL DE TRANSICION SELECCIONADO ENTRE Pd(OAC)2, TETRAQUIS-EN UN SOLVENTE POLAR ADECUADO TAL COMO ETANOL. DICHO COMPUESTO ES INTERMEDIARIO CLAVE PARA LA PREPARACION DE PIRIMIDINIL-AMINO-BENZAMIDAS SUSTITUIDAS
PE2006000628A 2005-06-09 2006-06-07 Procesos para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina PE20070109A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68897605P 2005-06-09 2005-06-09

Publications (1)

Publication Number Publication Date
PE20070109A1 true PE20070109A1 (es) 2007-04-02

Family

ID=37149980

Family Applications (3)

Application Number Title Priority Date Filing Date
PE2010000467A PE20100715A1 (es) 2005-06-09 2006-06-07 Proceso para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina
PE2010000468A PE20100716A1 (es) 2005-06-09 2006-06-07 Proceso para la sintesis de 1-bromo-3-nitro-5-trifluorometil-benceno
PE2006000628A PE20070109A1 (es) 2005-06-09 2006-06-07 Procesos para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PE2010000467A PE20100715A1 (es) 2005-06-09 2006-06-07 Proceso para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina
PE2010000468A PE20100716A1 (es) 2005-06-09 2006-06-07 Proceso para la sintesis de 1-bromo-3-nitro-5-trifluorometil-benceno

Country Status (25)

Country Link
US (2) US7781597B2 (es)
EP (3) EP2266961B1 (es)
JP (2) JP5225078B2 (es)
KR (2) KR101249199B1 (es)
CN (6) CN102180796A (es)
AR (1) AR057056A1 (es)
AT (1) ATE540931T1 (es)
AU (3) AU2006258050B2 (es)
BR (1) BRPI0611683A2 (es)
CA (4) CA2611280C (es)
DK (2) DK2292607T3 (es)
ES (3) ES2380489T3 (es)
GT (1) GT200600202AA (es)
HU (1) HUE028024T2 (es)
IN (2) IN2014DN08588A (es)
JO (1) JO2758B1 (es)
MX (1) MX2007015609A (es)
MY (1) MY146795A (es)
PE (3) PE20100715A1 (es)
PL (3) PL2266961T3 (es)
PT (3) PT2292607E (es)
RU (1) RU2446162C2 (es)
SI (2) SI2266961T1 (es)
TW (1) TWI380981B (es)
WO (1) WO2006135640A2 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101768129B (zh) 2004-03-05 2012-05-23 日产化学工业株式会社 异*唑啉取代苯甲酰胺化合物的制备中间体
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
CA2684671A1 (en) 2007-06-13 2008-12-18 E.I. Du Pont De Nemours And Company Isoxazoline insecticides
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
CA2685072C (en) 2007-06-27 2017-08-01 E. I. Du Pont De Nemours And Company Animal pest control method
TWI600639B (zh) 2007-08-17 2017-10-01 杜邦股份有限公司 製備５-鹵烷基-４，５-二氫異唑衍生物之化合物
KR20100075996A (ko) 2007-10-03 2010-07-05 이 아이 듀폰 디 네모아 앤드 캄파니 무척추 해충의 방제를 위한 나프탈렌 이속사졸린 화합물
TW201444787A (zh) * 2008-04-09 2014-12-01 Du Pont 製備３-三氟甲基查耳酮（ｃｈａｌｃｏｎｅ）之方法
US20100016590A1 (en) * 2008-07-17 2010-01-21 Teva Pharmaceutical Industries Ltd. Nilotinib intermediates and preparation thereof
EP2262793B1 (en) 2008-11-05 2012-10-03 Teva Pharmaceutical Industries Ltd. Nilotinib hci crystalline forms
WO2010060074A1 (en) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Preparation of nilotinib and intermediates thereof
US20110053968A1 (en) 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
MA34247B1 (fr) 2010-05-27 2013-05-02 Du Pont Forme cristalline du 4-[5-[3-chloro-5-(trifluorométhyl) phényl] -4,5-dihydro-5-(trifluorométhyl)-3-isoxazolyl]-n-[2-oxo-2-[(2, 2,2-trifluoroéthyl) amino] éthyl]-1-naphtalènecarboxamide
EP3617213B1 (en) 2011-12-30 2025-02-19 Hanmi Pharm. Co., Ltd. Thieno[3,2-d]pyrimidine derivatives having inhibitory activity for protein kinases
CN102592837B (zh) * 2012-03-12 2014-01-15 河北师范大学 制备超级电容器用四氯合金属季铵盐掺杂聚苯胺电极的方法
CN103694176B (zh) * 2014-01-07 2015-02-18 苏州立新制药有限公司 尼洛替尼中间体的制备方法
CN104592122B (zh) * 2014-12-09 2018-01-23 凯莱英医药集团（天津）股份有限公司 3‑(4‑甲基‑1h‑咪唑‑1‑基)‑5‑(三氟甲基)苯胺的制备方法
CN105985293B (zh) * 2015-03-04 2018-04-03 埃斯特维华义制药有限公司 尼洛替尼中间体的制备方法
EP3095782A1 (en) 2015-05-18 2016-11-23 Esteve Química, S.A. New method for preparing 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
CN107201532B (zh) * 2017-05-09 2019-08-27 吉林凯莱英医药化学有限公司 芳香化合物的硝化方法
US11053220B2 (en) 2018-01-01 2021-07-06 Laurus Labs Ltd Process for 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) aniline
CN108530364B (zh) * 2018-04-10 2020-01-21 江苏创诺制药有限公司 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用
CN112423757A (zh) 2018-06-15 2021-02-26 汉达生技医药责任有限公司 激酶抑制剂的盐类及其组合物
CA3136189A1 (en) * 2019-04-06 2020-10-15 Trinapco, Inc. Sulfonyldiazoles and n-(fluorosulfonyl)azoles, and methods of making the same
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride
CN114751836B (zh) * 2021-02-23 2024-05-31 四川青木制药有限公司 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺合成方法及其中间体
CN114853734A (zh) * 2022-06-14 2022-08-05 海南鑫开源医药科技有限公司 一种尼洛替尼游离碱的制备方法
CN116478319A (zh) * 2022-11-07 2023-07-25 华北电力大学 一种离子共价有机聚合物的制备方法及其在碱性环境吸附ReO4-的应用
CN115626880B (zh) * 2022-11-15 2023-11-14 常州大学 3-硝基-5-氰基三氟甲苯的合成方法
CN118108670A (zh) * 2023-12-28 2024-05-31 江苏希迪制药有限公司 一种尼罗替尼中间体3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺的精制纯化方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1051076A1 (ru) * 1982-04-09 1983-10-30 Алтайский политехнический институт Способ получени производных имидазола
GR851296B (es) * 1984-05-29 1985-11-25 Pfizer
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
GB0023383D0 (en) * 2000-09-23 2000-11-08 Synprotec Ltd 3,5-Bis (Trifluormethyl)Benzene derivatives
TW200406374A (en) * 2002-05-29 2004-05-01 Novartis Ag Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) 2002-09-27 2002-11-06 Novartis Ag Organic compounds
CN1939910A (zh) 2004-12-31 2007-04-04 孙飘扬 氨基嘧啶类化合物及其盐和其制备方法与药物用途
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
GT200600207A (es) * 2005-06-09 2007-01-15 Novartis Ag Proceso para la síntesis de compuestos orgánicos

Also Published As

Publication number Publication date
PT1896426E (pt) 2012-04-12
KR20120099028A (ko) 2012-09-06
JP2013035855A (ja) 2013-02-21
CN102180836A (zh) 2011-09-14
GT200600202AA (es) 2014-06-09
SI2266961T1 (sl) 2016-02-29
CA2833394A1 (en) 2006-12-21
PL2292607T3 (pl) 2014-09-30
KR20080014010A (ko) 2008-02-13
AU2011201044A1 (en) 2011-03-31
PT2266961E (pt) 2016-02-05
PL2266961T3 (pl) 2016-04-29
WO2006135640A3 (en) 2007-08-02
EP2292607A2 (en) 2011-03-09
CA2611280A1 (en) 2006-12-21
CA2611280C (en) 2014-01-28
WO2006135640A2 (en) 2006-12-21
CN102174020A (zh) 2011-09-07
AU2006258050A1 (en) 2006-12-21
US20100280257A1 (en) 2010-11-04
PT2292607E (pt) 2014-06-24
AU2010241374B2 (en) 2011-11-03
CN102180836B (zh) 2012-11-21
KR101283109B1 (ko) 2013-07-05
ES2558696T3 (es) 2016-02-08
TW200716563A (en) 2007-05-01
JP5225078B2 (ja) 2013-07-03
CN101189212A (zh) 2008-05-28
EP2266961A3 (en) 2011-07-27
KR101249199B1 (ko) 2013-04-03
US20080200692A1 (en) 2008-08-21
RU2007148238A (ru) 2009-07-20
CN102174021B (zh) 2013-02-27
EP1896426A2 (en) 2008-03-12
AU2006258050B2 (en) 2010-12-09
ATE540931T1 (de) 2012-01-15
CN102174019A (zh) 2011-09-07
ES2380489T3 (es) 2012-05-14
IN2014DN08578A (es) 2015-07-10
RU2446162C2 (ru) 2012-03-27
CN101189212B (zh) 2011-05-18
AR057056A1 (es) 2007-11-14
US8008504B2 (en) 2011-08-30
ES2465522T3 (es) 2014-06-06
CA2886482C (en) 2017-09-05
PE20100715A1 (es) 2010-10-25
EP1896426B1 (en) 2012-01-11
CN102180796A (zh) 2011-09-14
PE20100716A1 (es) 2010-10-25
EP2266961A2 (en) 2010-12-29
DK2292607T3 (da) 2014-06-30
ES2380489T8 (es) 2012-06-22
EP2292607A3 (en) 2011-04-27
CN102174020B (zh) 2012-11-07
SI2292607T1 (sl) 2014-09-30
MX2007015609A (es) 2008-02-25
PL1896426T3 (pl) 2012-06-29
CN102174021A (zh) 2011-09-07
TWI380981B (zh) 2013-01-01
DK2266961T3 (en) 2016-01-25
CA2886482A1 (en) 2006-12-21
JO2758B1 (en) 2014-03-15
CA2942046A1 (en) 2006-12-21
HUE028024T2 (en) 2016-11-28
CA2833394C (en) 2016-03-29
EP2266961B1 (en) 2015-10-21
BRPI0611683A2 (pt) 2010-09-28
IN2014DN08588A (es) 2015-07-10
US7781597B2 (en) 2010-08-24
AU2010241374A1 (en) 2010-12-02
MY146795A (en) 2012-09-28
EP2292607B1 (en) 2014-04-09
CN102174019B (zh) 2013-02-13
JP2008546645A (ja) 2008-12-25

Similar Documents

Publication Publication Date Title
PE20070109A1 (es) Procesos para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina
PE20070015A1 (es) Proceso para la sintesis de compuestos pirimidinilaminobenzamidas
EA200870586A1 (ru) 3-(1,3-бензодиоксол-5-ил)-6-(4-циклопропилпиперазин-1-ил)пиридазин, его соли и сольваты и его применение в качестве антагониста н3 рецептора гистамина
PE20131086A1 (es) Proceso para preparar compuestos antivirales
EA200701470A1 (ru) Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений
RU2010102137A (ru) Способ получения пиразолов
Liu et al. Copper-catalyzed annulation of α-substituted diazoacetates with 2-ethynylanilines: the direct synthesis of C2-functionalized indoles
Daniel et al. Intramolecular Metal‐Free N− N Bond Formation with Heteroaromatic Amines: Mild Access to Fused‐Triazapentalene Derivatives
Yi et al. Synthesis of 1, 2-Fused/Disubstituted Benzimidazoles and Benzimidazolium Salts by I2-Mediated sp3 C–H Amination
AR057351A1 (es) Proceso para la sintesis de imidazol bencilaminas
TW200705727A (en) Additive for nonaqueous flectrolyte and secondary battery using the same
DE602005008402D1 (de) Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole
DE60303273D1 (de) Verfahren zur Monomethylierung von stickstoffhaltigen Heterocyclen
CA2461060A1 (en) Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
Łukasik et al. Aryliminophosphoranes as key intermediates in the one-pot synthesis of 1-aryl-1, 3-dihydro-2H-benzimidazol-2-ones from N-aryl-2-nitrosoanilines and carbon dioxide under mild metal-free conditions
CA2482466A1 (en) Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
Talukdar et al. Ullmann-Type N-, S-, and O-Arylation Using a Well-Defined 7-Azaindole-N-oxide (7-AINO)-Based Copper (II) Catalyst: Scope and Application to Drug Synthesis
EA199900754A1 (ru) Способ получения замещенного тиазолидиндиона
WO2009012201A3 (en) Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamides
Pokhodylo et al. Synthesis of 2-azido-1, 3-thiazoles as 1, 2, 3-triazole precursors
BR0315671A (pt) Processo para a preparação de um composto
NO20054345L (no) Fremgangsmate for termisk stabilisering av hoykonsentrerte formaldehydlosninger
DK1971680T3 (da) Fremgangsmåde til fremstilling af dendritiske celler ved anvendelse af reduceret temperatur
Tanaka et al. Lithiation of Uracilnucleosides and its Application to the Synthesis of a New Class of Anti-HIV-1 Acyclonucleosides
NO20090349L (no) Fremgangsmate for fremstilling av nitrogen-inneholdende forbindelser

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载